Blog
EQS-News: Cryptology Asset Group p.l.c. (“Cryptology”) & Deutsche Digital Assets (“DDA”) - Joint Press Release
EQS-News: Cryptology Asset Group p.l.c. (“Cryptology”) & Deutsche Digital Assets (“DDA”) - Joint Press Release
SberBank selected RAS highlights for 12M 2022
SberBank selected RAS highlights for 12M 2022
EQS-News: Adler Group S.A.: review of 800,000 documents completed without any findings
EQS-News: Adler Group S.A.: review of 800,000 documents completed without any findings
Polymetal: Analyst and Investor Day
Polymetal: Analyst and Investor Day
Genel Energy PLC: Trading and operations update
Genel Energy PLC: Trading and operations update
Press Release: KPN nominates Frank Heemskerk to Supervisory Board and proposes to reappoint Jolande Sap
Press Release: KPN nominates Frank Heemskerk to Supervisory Board and proposes to reappoint Jolande Sap
EQS-News: Nordex Group generates order intake of 6.3 GW in the fiscal year 2022
EQS-News: Nordex Group generates order intake of 6.3 GW in the fiscal year 2022
EQS-News: STEMMER IMAGING confirms growth prospects with record order in the Artificial Vision segment
EQS-News: STEMMER IMAGING confirms growth prospects with record order in the Artificial Vision segment
Lindt & Sprüngli reports strong sales growth
Lindt & Sprüngli reports strong sales growth
Kinarus Therapeutics Reports Preclinical Data in Lung Fibrosis and Discloses Clinical Development Plan
Kinarus Therapeutics Reports Preclinical Data in Lung Fibrosis and Discloses Clinical Development Plan
Bellevue Asset Management launches debut private equity secondaries fund
Bellevue Asset Management launches debut private equity secondaries fund
Relief Therapeutics Announces IRB Approval of Investigator-Initiated Trial Evaluating RLF-TD011 as an Adjunctive Treatment for Cutaneous T-Cell Lymphom
Relief Therapeutics Announces IRB Approval of Investigator-Initiated Trial Evaluating RLF-TD011 as an Adjunctive Treatment for Cutaneous T-Cell Lymphom
A sharp rise in the cost basis, delayed reaction to a decline in demand and the effect of one-time impacts in the second half of 2022 led to a significant reduction in EBIT and Group profit.
A sharp rise in the cost basis, delayed reaction to a decline in demand and the effect of one-time impacts in the second half of 2022 led to a significant reduction in EBIT and Group profit.
Christoph Tonini to become Delegate of the Board and CEO of SMG Swiss Marketplace Group and step down from his mandates at TX Group
Christoph Tonini to become Delegate of the Board and CEO of SMG Swiss Marketplace Group and step down from his mandates at TX Group
EQS-News: AURELIUS Equity Opportunities to seek segment change
EQS-News: AURELIUS Equity Opportunities to seek segment change
EQS-Adhoc: Application for termination of stock exchange inclusion in Munich
EQS-Adhoc: Application for termination of stock exchange inclusion in Munich
EQS-News: Westwing Group SE Trading Update: FY 2022 financial guidance confirmed; positive Adjusted EBITDA and Free Cash Flow in the fourth quarter of 2022
EQS-News: Westwing Group SE Trading Update: FY 2022 financial guidance confirmed; positive Adjusted EBITDA and Free Cash Flow in the fourth quarter of 2022
Affluent Medical : Affluent Medical strengthens its management team to support industrial and commercial deployment
Affluent Medical : Affluent Medical strengthens its management team to support industrial and commercial deployment
ROCTOOL: STANDEX ENGRAVING AND ROCTOOL SIGN GLOBAL AGREEMENT
ROCTOOL: STANDEX ENGRAVING AND ROCTOOL SIGN GLOBAL AGREEMENT
Key Figures 15.01.2023
Key Figures
15.01.2023
Invibes Advertising NV: Half-yearly report on the liquidity contract
Invibes Advertising NV: Half-yearly report on the liquidity contract
EQS-News: va-Q-tec AG: Acceptance period for EQT Private Equity’s voluntary public takeover offer for va-Q-tec begins
EQS-News: va-Q-tec AG: Acceptance period for EQT Private Equity’s voluntary public takeover offer for va-Q-tec begins
Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc
Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc
Form 8.3 - The Vanguard Group, Inc.: Micro Focus International plc
Form 8.3 - The Vanguard Group, Inc.: Micro Focus International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc


